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Porphyrins are key precursors for development of photosensitizers for photodynamic therapy. A new
series of ortho-halogenated tetraarylporphyrins with sulfonamide substituents have been synthesized via
chlorosulfonation reaction and characterized by MALDI-TOFMS. To predict their partition properties,
log KOW of a selected range of the synthesized halogenated amphiphilic porphyrins is described. A sig-
nificant effect of the number and type of halogen group as well as on the number of sulfonamide side
chain was observed. The determined 1-octanol/water partition coefficients showed that it is possible to
obtain compounds with a wide range of lipophilicities, from log KOW¼2.71 till log KOW>4, which are
suitable to optimize the biological efficacy of this class of sensitizers.
 2008 Elsevier Ltd. All rights reserved.1. Introduction
Tetrapyrrolic macrocyles namely porphyrins1,2 and their re-
duced derivatives, chlorins3,4 and bacteriochlorins,5,6 have been
described as selective model sensitizers for photodynamic therapy
(PDT).7–10 We have shown that the singlet–triplet intersystem
crossing, and the consequent increase in singlet oxygen quantum
yield, can be improved in this class of sensitizers with the in-
troduction of halogen atoms in their structure.2,11 The performance
of the halogenated sensitizers in vitro was recently assessed and
met with the expectation of improved photodynamic activity.12
Further progress can be expected from the introduction of amphi-
philic properties in halogenated porphyrins, which will combine
high singlet–triplet intersystem crossings with enhanced lipid
bioavailability.13–16 Additionally, such porphyrins are synthetic
precursors of other sensitizers, such as chlorins and bacterio-
chlorins,17 which have strong absorptions at longer wavelengths.
The synthesis of meso-aryl halogenated porphyrins may follow
two basically different methodologies: the Lindsey two-step ap-
proach18–20 or the Gonsalves and Pereira nitrobenzene one-pot
method.21,22 In the first method, the step of the condensation of
pyrrole with the desired halogenated aldehyde to yield the por-
phyrinogen is separated from the second step of the oxidation ofx: þ351 239 827 703.
ra).
All rights reserved.the porphyrinogen to the corresponding porphyrins, using
dichlorodicyanoquinone (DDQ) or tetrachloro-1,4-benzoquinone
(chloranil) as oxidant. In the second approach, a simple mixture of
pyrrole and the aldehyde using organic acid and nitrobenzene in an
aerated solution and high temperatures gives, directly from the
reaction medium, the corresponding porphyrins. The Lindsey ap-
proach gives high yields but large dilutions and expensive quinones
are required, whichmake themethod quite expensive. On the other
hand, the nitrobenzene approach gives low yields with 5,10,15,20-
tetrakis(2,6-dichlorophenyl)porphyrin (TDCPP), but high concen-
trations can be used and pure porphyrins crystallize directly from
the reaction medium. In view of the economical advantages and of
the possibility of obtaining pure porphyrins, the second synthetic
method was selected for this study.
According to the literature, the aromatic electrophilic chloro-
sulfonation of porphyrins and corroles using chlorosulfonic acid is
an attractive method to obtain the corresponding chlorosulfonic
derivatives with high yields and purity. The chlorosulfonations
of 5,10,15,20-tetrakisphenylporphyrin (TPP), 5,10,15,20-tetra-
kis(2-chlorophenyl)porphyrin (TCPP) and TDCPP proceed with
excellent selectivity for the phenyl ring, as opposed to the selective
substitution of b-pyrrole H atoms in corroles23,24 yielding the
stable tetra-chlorosulfonated porphyrinic compounds with high
yields.12,25,26 These chlorosulfonates revealed also excellent re-
activities towards nucleophiles like water, amines, alcohols or
amino acids.12,23–28 Metallocomplexes of amphiphilic sulfonamide
porphyrins proved to be quite good catalysts for epoxidation of
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drogen peroxide as oxidant.30 Furthermore, the synthesis of am-
phiphilic corroles with sulfonic acid head groups and their multiple
applications on bio-mimetic catalysis,31,32 bio-medicine33,34 and
photovoltaic cells35 have been recently described by Gross.
This study presents the synthesis of a large set of amphiphilic
sulfonamide porphyrins, their characterization by matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOFMS), and the evaluation of their polarity in terms of
1-octanol/water partition coefficients (KOWs). As will be shown
below, MALDI-TOFMS is particularly well suited for the analysis of
these porphyrins because the only species observed is the Mþ ion.
The measurement of KOWs is motivated by the importance of this
hydrophilicity/lipophilicity index in Medicinal chemistry. Our
portfolio of sensitizers contains a large diversity of KOWs and is
particularly well suited to rationalize subsequent studies on the
properties of transport and biodistribution of tetrapyrrolic macro-
cycles as sensitizers in PDT.2. Results and discussion
2.1. Sulfonamide synthesis
The 5,10,15,20-tetrakis(2-chlorophenyl)porphyrin 1, 5,10,15,20-
tetrakis(2,6-dichlorophenyl)porphyrin 2 and 5,10,15,20-tetrakis(2-
fluorophenyl)porphyrin 3 were prepared by one-pot condensation
of pyrrole with the desired ortho-halogenated benzaldehyde using
acetic acid/nitrobenzene as solvent and oxidant, accordingly to
our previously described methodology.21,22 Using this synthetic
approach, crystals of pure halogenated porphyrins 1 and 2 were
obtained by direct crystallization from the reaction medium, in 4.5
and 9% isolated yields, respectively, which are in good agreement
with literature.21,22 To the best of our knowledge, this is the first
time that porphyrin 3 is described by this method, and a 20% yield
of pure crystals was obtained.N
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Scheme 1. Reagents and conditions: (i) 1, HSO3Cl, 50 C, 1 h, 94%; 2, HSO3Cl, 100 C, 3 h,
12 h, 100%.In order to synthesize the desired halogenated amphiphilic
porphyrins, the derivatization of 1, 2 and 3 into the corresponding
chlorosulfonated porphyrins was achieved by mixing the porphy-
rins with an excess of chlorosulfonic acid by optimization of tem-
peratures and reaction times. Reaction of 1with chlorosulfonic acid
at 50 C for 1 h affords the green tetra-substituted chlorosulfonyl
derivative 5,10,15,20-tetrakis(2-chloro-5-chlorosulfophenyl)por-
phyrin 4. After cooling to room temperature, dichloromethane is
added and the excess of acid is continuously extracted with water.
After work-up, we obtained 94% of 4. Due to the strong deactivation
effect of two chlorine atoms, the chlorosulfonation of porphyrin 2
was carried out at 100 C during 3 h. After similar work-up,
we obtained 92% of the 5,10,15,20-tetrakis(2,6-dichloro-3-chloro-
sulfophenyl)porphyrin 5. Porphyrin 3 was chlorosulfonated at
60 C for 1.5 h, yielding 97% of the 5,10,15,20-tetrakis(2-fluoro-5-
chlorosulfophenyl)porphyrin 6.
In spite of the remarkable stability of the chlorosulfonyl func-
tionality towards hydrolysis and chromatographic conditions, these
groups are susceptible to reactionwith amines.23,25–30 Thus, adding
an excess of the desired amine to a dichloromethane solution of the
chlorosulfonated porphyrin derivatives 4, 5 and 6, and maintaining
the reaction at room temperature for 3 h, yields the corresponding
sulfonamides (4a–e; 5a–e; 6a–e, see Scheme 1). After work-up,
we isolated our portfolio of amphiphilic sulfonamide porphyrin
derivatives with yields up to 75% (see Table 1).
In addition, the chlorosulfonated porphyrins 4, 5 and 6 were
suspended in water and maintained under reflux temperature for
12 h (see Scheme 1), yielding quantitatively the corresponding
sulfonic acid porphyrins derivatives 4f, 5f, and 6f (see Table 1).2.2. Characterization of porphyrins by MALDI-TOFMS
The new porphyrin derivatives presented in Table 1 were
characterized by the methods described in Section 4, and in par-
ticular by MALDI-TOFMS. Acidic matrices were initially employedO2Cl
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Table 1
Yields of sulfonamide and sulfonic acid porphyrin derivatives (4a–f; 5a–f; 6a–f)
Nucleophile TCPPSO2Cl (4)
derivatives
Yield
(%)
TDCPPSO2Cl (5)
derivatives
Yield
(%)
TFPPSO2Cl (6)
derivatives
Yield
(%)
NH2CH3 4a 75 5a 94 6a 78
NH2CH2CH3 4b 92 5b 96 6b 85
NH2(CH2)2CH3 4c 78 5c 89 6c 82
NH2(CH2)6CH3 4d 89 5d 84 6d 81
NH(CH2)5 4e 83 5e 95 6e 82
H2O 4f 100 5f 100 6f 100
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Figure 2. MALDI-TOFMS data for 6f, acquired with DHB.
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but positive radical ions (Mþ) were observed instead of the
expected [MþH]þ species.36 In general, the relative ionization
energies of porphyrin and matrix facilitate the charge-transfer
ionization mechanism. More recently, the charge-transfer matrix
2-[(2E)-3-(4-tert-butylphenyl)-2-methylprop-2-enylidene]malono-
nitrile (DCTB) has been shown to be very effective for the analysis
of porphyrins.37 MALDI-TOFMS spectra for 6e and 5c are given in
Figure 1. The spectra are easy to interpret because the only species
observed is the Mþ ion, with no aggregates, fragments or struc-
turally similar by-products from the synthesis. The isotope pattern
comparison lends further credence to the identification of the
target compound, as opposed to another compound of isobaric
nominal mass, especially for 5c, with the very distinctive pattern
arising from the eight chlorine atoms. However, MALDI-TOFMS
characterization of 6f was not as straight forward, as no ions were
observed when DCTB was used. With 2,5-dihydroxybenzoic acid
(DHB) matrix, the [MþH]þ species was observed strongly, while
there was no evidence for the Mþ species (see Fig. 2). In addition,
the [MþNa]þ and [MþK]þ species were observed, the cations being
provided by ubiquitous trace impurities from solvents. Low in-
tensity ions at slightly higher masses are artefacts of the MALDI-
TOFMS analysis, corresponding to the [MHþ2Na]þ and
[MHþNaþK]þ species arising from replacement of acidic protons
by metal cations. These data highlights the effect that peripheral
functional groups (sulfonic acid in this case) have not only on the
solubility of the porphyrin, but on the successful mode of ioniza-
tion, and therefore planning of experimental conditions for800 1240 1680 2120 2560 3000
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Figure 1. MALDI-TOFMS spectra for (a) 6e and (b) 5c, acquired with DCTB. Inset shows
comparison of theoretical (i) and observed (ii) isotope patterns.characterization by MALDI-TOFMS. The molecular ions Mþ of all
the sulfonamides are presented in Section 4.2.3. 1-Octanol/water partition coefficients
We evaluated the effect of the halogen atom and of the size of
carbon sulfonamide chain on the 1-octanol/water partition co-
efficients of the porphyrins using a minor modification of the
shake-flask method.38–40 The desired sulfonamide porphyrin was
dissolved in 1-octanol saturated with phosphate buffer (PBS). This
solutionwas then added to a PBS solution saturated with 1-octanol.
The mixture of the two solvents was vigorously stirred, centrifuged
and the solvents were separated. An appropriate volume of each
phase was taken and diluted with ethanol. The fluorescence of each
ethanol/1-octanol and ethanol/PBS solutions was measured, and
compared with a calibration curve to obtain the concentration of
the photosensitizer. The solutions for the calibration curves were
either ethanol/1-octanol or ethanol/PBS, with precisely weighted
amounts of the appropriate photosensitizer. The absorption band
ca. 420 nm was excited, and the fluorescence was collected in the
red region, under the same instrumental conditions for both the
calibration curve and the samples. With this method we were able
to obtain calibration curves for ethanol/PBS down to porphyrin
concentrations of 107 M. The experiments with compounds 4f, 5f
and 6f were done in a similar way, but the sensitizers have been
firstly dissolved in PBS solution saturated with 1-octanol. The
partition coefficients were calculated according to the ratio Coct/
CPBS, where Coct and CPBS are the concentrations of the sulfonamide
porphyrin in the 1-octanol and in the PBS, respectively, and are
presented in Table 2.Table 2
Partition coefficients (log KOW) in 1-octanol/water of selected sulfonamide and
sulfonic acid porphyrin derivatives
Sulfonamide derivatives log KOW
4b 2.230.05
4f 2.710.31
5b 1.840.12
5f 1.800.38
6a 2.330.29
6b 2.530.08
6c 2.430.21
6d >4a
6e >4a
6f 2.490.33
a Estimated from the absence of fluorescence in the aqueous phase.
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porphyrins show that it is possible to obtain a range of very hy-
drophilic to very hydrophobic compounds. The log KOW of these
sensitizersdependson thenumberand typeofhalogensubstituents.
It decreaseswith the number of chlorine atoms in the ortho-position
of thephenyl ring (4b,5b), and increaseswith the replacementof the
chlorine atom by the less polarizable fluorine atom (4b, 6b). As
a result, the most lipophilic halogenated-ethylsulfamoylphenyl
porphyrin is 6b. The lipophilicity of fluorinated-alkylsulfamoyl-
phenyl porphyrins can be further enhanced by increasing the size of
the sulfonamide alkyl side chain. On the range of the fluorinated-
alkylsulfamoylphenyl porphyrins, 6a–6c, it is evident that changing
the alkyl chain frommethyl to ethyl or propyl, the obtained value of
log KOW is within the experimental error, but sulfonamides with
higher carbon atoms on the alkyl chains (6d and 6e), were not de-
tectable by fluorescence in the aqueous phase. In the experimental
conditions of this study, the detection limit is sub-nanomolar,which
requires log KOW>4. Furthermore the log KOW of compounds 4f, 5f
and 6f is always negative.
It is evident that simple and efficient synthetic methods can
be used to tune the lipophilicity of sulfonamide porphyrins, by
selecting the type and number of halogen atoms as well as the size
of the alkyl sulfonamide chain. We note, in passing, that sub-
nanomolar quantities of fluorinated-alkylsulfamoylphenyl por-
phyrins can be detected in aqueous solution by fluorescence
spectroscopy. This can be very useful for diagnosis and adds to the
well-known use of fluorinated compounds as probes in magnetic
resonance imaging.41–43
3. Conclusions
The chlorosulfonation of the phenyl ring of ortho-halogenated
phenyl porphyrins is a convenient method to prepare high yields of
pure and stable chlorosulfonated derivatives. The chlorosulfonyl
compounds easily react with the desired amines or water to give
a large portfolio of amphiphilic halogenated porphyrins with very
good yields. The use of MALDI-TOFMS using the DCTB matrix
revealed to be an excellent approach to obtain Mþ for all the sul-
fonamides without any fragmentation. The determination of 1-
octanol/water partition coefficients showed that by changing the
halogen atom and/or the side chain it is possible to obtain com-
pounds with a wide range of lipophilicities, from log KOW¼2.71
till log KOW>4, which are needed to optimize the biological efficacy
of this class of sensitizers. Furthermore, the sub-nanomolar quan-
tities of fluorinated-alkylsulfamoylphenyl porphyrins detected by
fluorescence spectroscopy enlarge the possibilities of using these
sensitizers for in vivo diagnosis.
4. Experimental
4.1. General
UV–visible absorption spectra were recorded on a Hitachi
U-2010 in quartz cells. The molar absorption coefficients were
determined in toluene and PBS solutions. The fluorescence spectra
for the determination of the 1-octanol/water partition coefficient
were acquired on a Spex Fluorolog 3 spectrophotometer. Elemental
analyses were carried out on a Fisons Instruments EA 1108 CHNS-O
elemental analyser. Melting points were measured on an Electro-
thermal capillary melting point apparatus. 1H NMR and 19F NMR
and 13C NMR spectra were recorded on a 300 MHz Brucker-Amx. 1H
assignments were made using 2D COSY and NOESY experiments,
while 13C assignments were made using 2D HSQC and HMBC ex-
periments. MALDI-TOFMS data were acquired using an Applied
Biosystems Voyager DE-STR instrument (Framingham, MA, USA.),
which is equipped with a nitrogen laser (l¼337 nm).All the solvents used in the synthesis of the sulfonamide halo-
genated porphyrins were purified by standard methods before
use.44 The dichloromethane and chloroform used in the column
chromatography by silica gel was neutralized with neutral active
alumina. All the reactants used for the synthesis of sulfonamide
halogenated porphyrins were purchased from Sigma and used as
received. The 1-octanol used on the determination of the 1-octanol/
water coefficient partition was obtained from Merck. DCTB and
DHB matrices were purchased from Fluka. HPLC grade solvents
were used for MALDI-TOFMS analysis; dichloromethane and
acetonitrile were purchased from Fischer Scientific, while ethanol
was purchased from Sigma-Aldrich.
4.2. General porphyrin synthesis
The synthesis of porphyrins 1, 2 and 3 were carried out by
nitrobenzene method21,22 prepared by the condensation of the
desired halogenated arylaldehyde (43 mmol) with pyrrole (3 mL,
43 mmol) in a mixture of acetic acid (140 mL, 2.45 mol) and
nitrobenzene (70 mL, 0.68 mol) at 120 C (1 h). The solution was
cooled to room temperature and 50 mL of methanol was added to
promote precipitation. The crystals of the porphyrins were filtered
off, washed with methanol and dried. By this method, very pure
crystals of porphyrins were obtained without further purification
procedures. Porphyrins 1 and 2 were obtained with yields 9 and
4.5%, respectively. Their identity was confirmed by NMR, FAB and
microanalysis, with good agreement with literature data.21,22
5,10,15,20-Tetrakis(2-fluorophenyl)porphyrin 3was prepared as
described above but 1.328 g (20%) of pure crystals were obtained.
4.2.1. 5,10,15,20-Tetrakis(2-fluorophenyl)porphyrin (3)
Yield (1.328 g, 20%); Mp>300 C; MS (EI), m/z: 686.2086 Mþ,
(calcd for C44H26N4F4, 686.2088 M
þ); 1H NMR (300 MHz, CDCl3)
d ppm 8.84 (s, 8H, b-H), 8.15–8.12 (m, 4H, Ph–H), 7.81–7.78 (m, 4H,
Ph–H), 7.58–7.49 (m, 8H, Ph–H),2.78 (s, 2H, NH); UV–vis (toluene)
lmax/nm (3/M
1 cm1) 417 (5.0105), 511 (2.8104), 543 (7.3103),
587 (8.1103), 653 (5.4103).
4.3. General procedure for chlorosulfonation of porphyrins
Chlorosulfonation of the halogenated porphyrins was carried
out according to a method developed previously.25 The required
porphyrin (200 mg) and chlorosulfonic acid (10 mL,150 mmol)were
stirred at 50 C 1, 100 C 2 and 60 C 3 for 1, 3 and 1.5 h, respectively.
After this period, dichloromethane (200 mL) was added to the so-
lution. A continuous water extraction was carried out, with stirring,
until neutralization. The dichloromethane solutionwas thenwashed
with sodium hydrogen carbonate and dried over anhydrous Na2SO4.
The purification by column chromatography in silica gel using
dichloromethane as eluent, and subsequent solvent evaporation
yielded the desired chlorosulfonated porphyrins as purple crystals.
4.3.1. 5,10,15,20-Tetrakis(2-chloro-5-chlorosulfonylphenyl)-
porphyrin (4)
Yield (288 mg, 94%); Mp>300 C; MS (FAB), m/z: 1147 [MþH]þ;
1H NMR (300 MHz, CDCl3) d ppm 8.90–8.76 (m, 4H, Ph–H), 8.70 (s,
8H, b-H), 8.49–8.46 (m, 4H, Ph–H), 8.17–8.13 (m, 4H, Ph–H), 2.71
(s, 2H, NH); UV–vis (toluene) lmax/nm (3/M
1 cm1) 423 (2.3105),
513 (1.4104), 545 (2.1103), 589 (4.2103), 645 (5.4102). Anal.
Calcd for C44H22N4O8Cl8S4$2H2O: C, 44.69; H, 2.22; N, 4.74; S, 10.80.
Found: C, 44.82; H, 2.77; N, 4.24; S, 10.66.
4.3.2. 5,10,15,20-Tetrakis(2,6-dichloro-3-chlorosulfonylphenyl)-
porphyrin (5)
Yield (264 mg, 92%); Mp>300 C; MS (FAB),m/z: 1285 [MþH]þ;
1H NMR (300 MHz, CDCl3) d ppm 8.67–8.63 (m, 12H, b-H and
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lmax/nm (3/M
1 cm1) 421 (3.2105), 514 (2.1104), 544 (2.6103),
590 (6.7103), 650 (8.2102). Anal. Calcd for C44H18N4O8Cl12S4: C,
41.15; H, 1.41; N, 4.36. Found: C, 40.70; H, 1.60; N, 4.30.
4.3.3. 5,10,15,20-Tetrakis(2-fluoro-5-chlorosulfonylphenyl)-
porphyrin (6)
Yield (302 mg, 97%); Mp>300 C; MS (MALDI-TOF), m/z: 1079.8
Mþ; 1H NMR (300 MHz, CDCl3) d ppm 8.90–8.86 (m, 12H, b-H and
Ph–H), 8.60–8.55 (m, 4H, Ph–H), 7.84–7.79 (m, 4H, Ph–H), 2.84 (s,
2H, NH); 19F NMR (282 MHz, CDCl3) d ppm 120.93 (m, 4F, o-F);
UV–vis (toluene) lmax/nm (3/M
1 cm1) 420 (3.7105), 511
(2.4104), 543 (4.7103), 586 (7.5103), 643 (1.1103). Anal. Calcd
for C44H22N4O8Cl4F4S4: C, 48.90; H, 2.05; N, 5.18; S, 11.87. Found: C,
48.06; H, 2.27; N, 5.45; S, 11.90.
4.4. General procedure for hydrolysis
Suspensions of above chlorosulfonated porphyrins (100 mg)
in distilled water (120 mL) were refluxed for 12 h. The resulting
solutions were concentrated by rotary evaporation and the solid
obtained was dried at 120 C.
The sulfonic acid porphyrin derivatives 5,10,15,20-tetrakis(2-
chloro-5-sulfonylphenyl)porphyrin 4f and 5,10,15,20-tetrakis(2,6-
dichloro-3-sulfonylphenyl)porphyrin 5f were obtained with
quantitative yields. They were characterized by NMR; FAB and
microanalysis, with good agreement with literature data.12,26
5,10,15,20-Tetrakis(2-fluoro-5-sulfophenyl)porphyrin 6f was
prepared as described above and obtained also with quantitative
yield.
4.4.1. 5,10,15,20-Tetrakis(2-fluoro-5-sulfophenyl)porphyrin (6f)
Compound 6 (100 mg, 0.093 mmol) in distilled water was
refluxed. Following the procedure described above was obtained
the solid of the corresponding sulfonic acid porphyrin derivative 6f.
Yield (93 mg, 100%). Mp>300 C; MS (MALDI-TOF), m/z: 1007.0
[MþH]þ; 1H NMR (300 MHz, CD3OD) d ppm 9.22 (s, 8H, b-H),
8.63(br s, 4H, Ph–H), 8.32 (br s, 4H, Ph–H), 7.88–782 (m, 4H, Ph–H);
UV–vis (H2O/PBS) lmax/nm (3/M
1 cm1) 410 (4.1105), 511
(1.7104), 547 (3.4103), 577 (6.5103), 629 (1.4103).
4.5. General procedure for the synthesis of sulfonamide
halogenated porphyrins
A sample of chlorosulfonated porphyrin (0.1 mmol) was dis-
solved in dried dichloromethane (50 mL), and the amine
(1.2 mmol) was added. The reaction mixture was stirred at room
temperature for 3 h. The organic phase was then washed with
a solution of HCl 1 M (3), with a saturated solution of sodium
hydrogen carbonate (2), with distilled water (2), and then was
dried over anhydrous Na2SO4. The solvent was concentrated by
rotatory evaporation and the resulting solid was purified using
silica gel chromatography with CHCl3/EtOAc (4:1) mixture as
eluent. Evaporation of the solvent and recrystallization of the
residue using CH2Cl2/CH3OH or CH2Cl2/pentane gave the respective
sulfonamide halogenated porphyrin.
4.5.1. 5,10,15,20-Tetrakis(2-chloro-5-N-methylsulfamoylphenyl)-
porphyrin (4a)
Initially, 0.6 mL (1.2 mmol) of a methylamine solution (THF,
2 M), was added to 4 (115 mg, 0.1 mmol) previously dissolved in
dichloromethane (50 mL). Following the procedure described
above, the solid of 4a was obtained (84 mg, 75%). Mp>300 C; MS
(MALDI-TOF), m/z: 1124.0 Mþ; 1H NMR (300 MHz, CDCl3) d ppm
8.70–8.57 (m, 12H, b-H and Ph–H), 8.29–8.26 (m, 4H, Ph–H),
8.07–8.03 (m, 4H, Ph–H), 4.63–4.59 (m, 4H, –NHCH3), 2,81 (s,12H, –NHCH3), 2.72 (s, 2H, NH); UV–vis (toluene) lmax/nm
(3/M1 cm1) 419 (2.3105), 513 (1.8104), 544 (2.8103),
588 (5.3103), 645 (6.8102). Anal. Calcd for C48H38Cl4N8O8S4: C,
51.25; H, 3.40; N, 9.96; S, 11.40. Found: C, 51.06; H, 3.47; N, 9.75;
S, 11.55.
4.5.2. 5,10,15,20-Tetrakis(2-chloro-5-N-ethylsulfamoylphenyl)-
porphyrin (4b)
Initially, 0.6 mL (1.2 mmol) of an ethylamine solution (THF, 2 M),
was added to 4 (115 mg, 0.1 mmol) previously dissolved in
dichloromethane (50 mL). Following the procedure described
above, the solid of 4bwas obtained (109 mg, 92%). Mp 270–271 C;
MS (MALDI-TOF),m/z: 1180.1Mþ; 1H NMR (300 MHz, CDCl3) d ppm
8.68–8.54 (m, 12H, b-H and Ph–H), 8.26–8.24 (m, 4H, Ph–H), 7.98–
7.82 (m, 4H, Ph–H), 4.64–4.61 (m, 4H, –NHCH2CH3), 3.26–3.14 (m,
8H, –NHCH2CH3), 1.25–1.09 (m, 12H, –NHCH2CH3), 2.74 (s, 2H,
NH); UV–vis (toluene) lmax/nm (3/M
1 cm1) 421 (3.5105), 513
(2.2104), 542 (4.6103), 589 (6.8103), 647 (1.9103). Anal. Calcd
for C52H46Cl4N8O8S4: C, 52.88; H, 3.93; N, 9.49; S, 10.86. Found: C,
52.59; H, 3.89; N, 9.55; S, 10.90.
4.5.3. 5,10,15,20-Tetrakis(2-chloro-5-N-propylsulfamoylphenyl)-
porphyrin (4c)
Initially, 0.1 mL (1.2 mmol) of propylamine, was added to 4
(115 mg, 0.1 mmol) previously dissolved in dichloromethane
(50 mL). Following the procedure described above, the solid of 4c
was obtained (96 mg, 78%). Mp 232–233 C; MS (MALDI-TOF),m/z:
1236.1 Mþ; 1H NMR (300 MHz, CDCl3) d ppm 8.68–8.56 (m, 12H,
b-H and Ph–H), 8.27–8.25 (m, 4H, Ph–H), 8.01–7.96 (m, 4H, Ph–H),
4.65–4.61 (m, 4H, –NHCH2CH2CH3), 3.15–3.09 (m, 8H, –NHCH2-
CH2CH3), 1.28–1.23 (m, 8H, –NHCH2CH2CH3), 0.95–0.87 (m, 12H,
–NHCH2CH2CH3), 2.72 (s, 2H, NH); UV–vis (toluene) lmax/nm
(3/M1 cm1) 419 (2.3105), 513 (1.8104), 543 (2.8103), 588
(5.3103), 645 (6.8102). Anal. Calcd for C56H54Cl4N8O8S4: C, 54.37;
H, 4.40; N, 9.06; S, 10.37. Found: C, 54.53; H, 4.21; N, 8.95; S, 10.46.
4.5.4. 5,10,15,20-Tetrakis(2-chloro-5-N-heptylsulfamoylphenyl)-
porphyrin (4d)
Initially, 0.18 mL (1.2 mmol) of heptylamine, was added to 4
(115 mg, 0.1 mmol) previously dissolved in dichloromethane
(50 mL). Following the procedure described above, the solid of 4d
was obtained (130 mg, 89%). Mp 195–196 C;MS (MALDI-TOF),m/z:
1460.4 Mþ; 1H NMR (300 MHz, CDCl3) d ppm 8.68–8.57 (m, 12H,
b-H and Ph–H), 8.26–8.24 (m, 4H, Ph–H), 8.00–7.88 (m, 4H, Ph–H),
4.66–4.61 (m, 4H, –NHCH2(CH2)5CH3), 3.18–3.10 (m, 8H, –NHCH2-
(CH2)5CH3), 1.23–1.19 (m, 40H, –NHCH2(CH2)5CH3), 0.83–0.76 (m,
12H, –NHCH2(CH2)5CH3), 2.72 (s, 2H, NH); UV–vis (toluene)
lmax/nm (3/M
1 cm1) 420 (2.3105), 513 (1.4104), 544 (2.5103),
589 (4.1103), 648 (9.0102). Anal. Calcd for for C72H86Cl4N8O8S4:
C, 59.17; H, 5.93; N, 7.67; S, 8.78. Found: C, 59.06; H, 6.07; N, 7.65;
S, 8.61.
4.5.5. 5,10,15,20-Tetrakis(2-chloro-5-N-piperidylsulfamoylphenyl)-
porphyrin (4e)
Initially, 0.12 mL (1.2 mmol) of piperidine, was added to 4
(115 mg, 0.1 mmol) previously dissolved in dichloromethane
(50 mL). Following the procedure described above, the solid of 4e
was obtained (111 mg, 83%). Mp>300 C; MS (MALDI-TOF), m/z:
1340.2 Mþ; 1H NMR (300 MHz, CDCl3) d ppm 8.65 (s, 8H, b-H),
8.60–8.49 (m, 4H, Ph–H) 8.18–8.16 (m, 4H, Ph–H), 8.04–8.00 (m,
4H, Ph–H), 3.21 (br s, 16H, –N(CH2)2(CH2)3), 1.59 (br s, 24H,
–N(CH2)2(CH2)3), 2.70 (s, 2H, NH); UV–vis (toluene) lmax/nm
(3/M1 cm1) 420 (6.4105); 513 (3.4104); 544 (6.3103);
588 (1.1104); 645 (1.7102). Anal. Calcd for C64H62Cl4N8O8S4:
C, 57.31; H, 4.66; N, 8.35; S, 9.56 Found: C, 57.85; H, 4.48; N, 8.23;
S, 9.21.
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phenyl)porphyrin (5a)
Initially, 0.6 mL (1.2 mmol) of a methylamine solution (THF,
2 M), was added to 5 (128 mg, 0.1 mmol) previously dissolved in
dichloromethane (50 mL). Following the procedure described
above, the solid of 5awas obtained (129 mg, 94%). Mp>300 C; MS
(MALDI-TOF), m/z: 1261.9 Mþ; 1H NMR (300 MHz, CDCl3) d ppm
8.63–8.57 (m, 12H, b-H and Ph–H), 8.03–7.99 (m, 4H, Ph–H),
5.02–4.99 (m, 4H, –NHCH3), 2.89 (s, 12H, –NHCH3), 2.55 (s, 2H,
NH); UV–vis (toluene) lmax/nm (3/M
1 cm1) 421 (2.6105), 515
(1.7104), 552 (2.4103), 595 (5.3103), 654 (1.2103). Anal. Calcd
for C48H34Cl8N8O8S4: C, 45.66; H, 2.71; N, 8.87; S, 10.16. Found: C,
46.06; H, 2.57; N, 8.75; S, 9.85.
4.5.7. 5,10,15,20-Tetrakis(2,6-dichloro-3-N-ethylsulfamoyl-
phenyl)porphyrin (5b)
Initially, 0.6 mL (1.2 mmol) of an ethylamine solution (THF,
2 M), was added to 5 (128 mg, 0.1 mmol) previously dissolved
in dichloromethane (50 mL). Following the procedure described
above, the solid of 5bwas obtained (126 mg, 96%). Mp 298–299 C;
MS (MALDI-TOF),m/z: 1317.9Mþ; 1H NMR (300 MHz, CDCl3) d ppm
8.64–8.36 (m, 12H, b-H and Ph–H), 8.00–7.95 (m, 4H, Ph–H), 5.11–
5.03 (m, 4H, –NHCH2CH3), 3.29–3.09 (m, 8H, –NHCH2CH3), 1.18–
1.15 (m,12H, –NHCH2CH3),2.55(s, 2H, NH); UV–vis (toluene) lmax/
nm (3/M1 cm1) 421 (2.4105), 516 (1.7104), 549 (3.8103), 597
(6.1103), 652 (5.2103). Anal. Calcd for C52H42Cl8N8O8S4: C, 47.36;
H, 3.21; N, 8.50; S, 9.73. Found: C, 47.21; H, 3.27; N 8.48; S, 9.75.
4.5.8. 5,10,15,20-Tetrakis(2,6-dichloro-3-N-propylsulfamoyl-
phenyl)porphyrin (5c)
Initially, 0.1 mL (1.2 mmol) of propylamine, was added to 5
(128 mg, 0.1 mmol) previously dissolved in dichloromethane
(50 mL). Following the procedure described above, the solid of 5c
was obtained (122 mg, 89%). Mp 259–260 C; MS (MALDI-TOF),
m/z: 1374.0 Mþ; 1H NMR (300 MHz, CDCl3) d ppm 8.60 (s, 8H, b-H),
8.58 (d, J¼8.7 Hz, 4H, Ph–H), 7.99 (d, J¼8.7 Hz, 4H, Ph–H), 5.05–5.09
(m, 4H, –NHCH2CH2CH3), 3.22–3.15 (m, 8H, –NHCH2CH2CH3), 1.69–
1.61 (m, 8H, –NHCH2CH2CH3), 1.02–0.96 (m, 12H, –NHCH2CH2CH3),
2.55 (s, 2H, NH); UV–vis (toluene) lmax/nm (3/M1 cm1) 420
(4.1105), 514 (2.3104), 541 (3.3103), 595 (7.5103), 649
(9.2102). Anal. Calcd for C56H50Cl8N8O8S4: C, 48.92; H, 3.67; N,
8.15; S, 9.33. Found: C, 49.05; H, 3.71; N, 7.95; S, 9.21.
4.5.9. 5,10,15,20-Tetrakis(2,6-dichloro-3-N-heptylsulfamoyl-
phenyl)porphyrin (5d)
Initially, 0.18 mL (1.2 mmol) of heptylamine, was added to 5
(128 mg, 0.1 mmol) previously dissolved in dichloromethane
(50 mL). Following the procedure described above, the solid of 5d
was obtained (134 mg, 84%). Mp 140–141 C;MS (MALDI-TOF),m/z:
1598.3 Mþ; 1H NMR (300 MHz, CDCl3) d ppm 8.60 (s, 8H, b-H), 8.58
(d, J¼8.6 Hz, 4H, Ph–H), 7.94 (d, J¼8.6 Hz, 4H, Ph–H), 5.05–5.03 (m,
4H, –NHCH2(CH2)5CH3), 3.23–3.17 (m, 8H, –NHCH2(CH2)5CH3),1.34–
1.24 (m, 40H, –NHCH2(CH2)5CH3), 0.86–0.83 (m, 12H, –NHCH2-
(CH2)5CH3), 2.54 (s, 2H, NH); UV–vis (toluene) lmax/nm (3/
M1 cm1) 422 (2.8105), 514 (4.2104), 548 (1.5103), 590 (3.0
103), 648 (3.9102). Anal. Calcd for for C72H82Cl8N8O8S4: C, 54.07;
H, 5.17; N, 7.01; S, 8.02. Found: C, 54.18; H, 5.22; N, 6.90; S, 8.04.
4.5.10. 5,10,15,20-Tetrakis(2,6-dichloro-3-N-piperidylsulfamoyl-
phenyl)porphyrin (5e)
Initially, 0.12 mL (1.2 mmol) of piperidine, was added to 5
(128 mg, 0.1 mmol) previously dissolved in dichloromethane
(50 mL). Following the procedure described above, the solid of 5e
was obtained (140 mg, 95%). Mp>300 C; MS (MALDI-TOF), m/z:
1478.1 Mþ; 1H NMR (300 MHz, CDCl3) d ppm 8.60 (s, 8H, b-H), 8.54
(d, J¼8.6 Hz, 4H, Ph–H), 7.94 (d, J¼8.6 Hz, 4H, Ph–H), 3.41 (br s, 16H,–N(CH2)2(CH2)3), 1.58 (br s, 24H, –N(CH2)2(CH2)3), 2.54 (s, 2H,
NH); UV–vis (toluene) lmax/nm (3/M
1 cm1) 420 (4.7105), 514
(2.6104), 541 (3.7103), 591 (8.3103), 647 (1.1103). Anal. Calcd
for C64H58Cl8N8O8S4: C, 51.97; H, 3.95; N, 7.58; S, 8.67. Found: C,
52.01; H, 4.03; N, 7.35; S, 8.81.
4.5.11. 5,10,15,20-Tetrakis(2-fluoro-5-N-methylsulfamoylphenyl)-
porphyrin (6a)
Initially, 0.6 mL (1.2 mmol) of a methylamine solution (THF,
2 M), was added to 6 (108 mg; 0.1 mmol) previously dissolved in
dichloromethane (50 mL). Following the procedure described
above, the solid of 6a was obtained (82 mg, 78%). Mp 298–299 C;
MS (MALDI-TOF), m/z: 1058.2 Mþ; 1H NMR (300 MHz, CDCl3)
d ppm 8.80 (s, 8H, b-H), 8.68–8.58 (m, 4H, Ph–H), 8.37–8.33 (m, 4H,
Ph–H), 7.72–7.61 (m, 4H, Ph–H), 4.60–4.57 (m, 4H, –NHCH3), 2.88–
2.82 (m, 12H, –NHCH3), 2.86 (s, 2H, NH); UV–vis (toluene) lmax/
nm (3/M1 cm1) 419 (1.5105), 512 (8.4103), 543 (1.5103), 589
(2.2103), 645 (4.4102). Anal. Calcd for C48H38F4N8O8S4: C, 54.43;
H, 3.62; N, 10.58; S, 12.11. Found: C, 54.24; H, 3.74; N, 10.76; S, 11.91.
4.5.12. 5,10,15,20-Tetrakis(2-fluoro-5-N-ethylsulfamoylphenyl)-
porphyrin (6b)
Initially, 0.6 mL (1.2 mmol) of an ethylamine solution (THF, 2 M),
was added to 6 (108 mg; 0.1 mmol) previously dissolved in
dichloromethane (50 mL). Following the procedure described
above, the solid of 6b was obtained (95 mg, 85%). Mp>300 C; MS
(MALDI-TOF), m/z: 1114.2 Mþ; 1H NMR (300 MHz, CDCl3) d ppm
8.79 (s, 8H, b-H), 8.66–8.62 (m, 4H, Ph–H), 8.36–8.32 (m, 4H, Ph–H),
7.70–7.62 (m, 4H, Ph–H), 4.64–4.59 (m, 4H, –NHCH2CH3), 3.27–3.19
(m, 8H, –NHCH2CH3), 1.28–1.17 (m, 12H, –NHCH2CH3), 2.86 (s, 2H,
NH); 19F NMR (282 MHz, CDCl3), 127.00 (m, 4F, o-F); UV–vis
(toluene) lmax/nm (3/M
1 cm1) 419 (3.3105), 512 (1.9104), 544
(2.3103), 588 (5.7103), 646 (1.5103). Anal. Calcd for
C52H46F4N8O8S4: C, 56.00; H, 4.16; N, 10.05; S, 11.50. Found: C,
56.57; H. 4.27; N, 9.92; S, 10.91.
4.5.13. 5,10,15,20-Tetrakis(2-fluoro-5-N-propylsulfamoylphenyl)-
porphyrin (6c)
Initially, 0.1 mL (1.2 mmol) of propylamine, was added to 6
(108 mg; 0.1 mmol) previously dissolved in dichloromethane
(50 mL). Following the procedure described above, the solid of 6c
was obtained (96 mg, 82%). Mp 210–211 C; MS (MALDI-TOF), m/z:
1170.3Mþ; 1HNMR (300 MHz, CDCl3) d ppm8.78 (s, 8H, b-H), 8.65–
8.62 (m, 4H, Ph–H), 8.34–8.30 (m, 4H, Ph–H), 7.65–7.59 (m, 4H,
Ph–H), 4.73–4.67 (m, 4H, –NHCH2CH2CH3), 3.17–3.09 (m, 8H,
–NHCH2CH2CH3), 1.61–1.51 (m, 8H, –NHCH2CH2CH3), 0.96–0.84 (m,
12H, –NHCH2CH2CH3),2.87 (s, 2H, NH); UV–vis (toluene) lmax/nm
(3/M1 cm1) 418 (3.8105), 511 (2.8104), 543 (6.0103), 586
(8.6103), 644 (1.6103). Anal. Calcd for C56H54F4N8O8S4: C, 57.42;
H, 4.65; N, 9.57; S, 10.95. Found: C, 57.47; H, 4.54; N, 9.65; S, 10.83.
4.5.14. 5,10,15,20-Tetrakis(2-fluoro-5-N-heptylsulfamoylphenyl)-
porphyrin (6d)
Initially, 0.18 mL (1.2 mmol) of heptylamine, was added to
6 (108 mg; 0.1 mmol) previously dissolved in dichloromethane
(50 mL). Following the procedure described above, the solid of 6d
was obtained (104 mg, 81%). Mp 134–135 C;MS (MALDI-TOF),m/z:
1394.5 Mþ; 1H NMR (300 MHz, CDCl3) d ppm 8.79 (s, 8H, b-H),
8.67–8.63 (m, 4H, Ph–H), 8.36–8.35 (m, 4H, Ph–H), 7.70–7.61 (m,
4H, Ph–H), 4.63–4.59 (m, 4H, –NHCH2(CH2)5CH3), 3.20–3.14 (m, 8H,
–NHCH2(CH2)5CH3), 1.28–1.21 (m, 40H, –NHCH2(CH2)5CH3), 0.88–
0.79 (m, 12H, –NHCH2(CH2)5CH3), 2.87 (s, 2H, NH); UV–vis (tol-
uene) lmax/nm (3/M
1 cm1) 419 (1.6105), 512 (1.1104),
542 (2.7103), 587 (3.6103), 644 (9.2102). Anal. Calcd for
C72H86F4N8O8S4: C, 61.96; H, 6.21; N, 8.03; S, 9.19. Found: C, 61.74;
H, 6.33; N, 7.83; S, 9.31.
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phenyl)porphyrin (6e)
Initially, 0.12 mL (1.2 mmol) of piperidine, was added 6 (108 mg;
0.1 mmol) previously dissolved in dichloromethane (50 mL). Fol-
lowing the procedure described above, the solid of 6ewas obtained
(113 mg, 82%). Mp 228–229 C; MS (MALDI-TOF), m/z: 1274.3 Mþ;
1H NMR (300 MHz, CDCl3) d ppm 8.81 (s, 8H, b-H), 8.62–8.55 (m,
4H, Ph–H) 8.29–8.23 (m, 4H, Ph–H), 7.73–7.68 (m, 4H, Ph–H), 3.22
(br s, 16H, –N(CH2)2(CH2)3), 1.60 (br s, 24H, –N(CH2)2(CH2)3), 2.83
(s, 2H, NH); 19F NMR (282 MHz, CDCl3) d ppm 127.05 (m, 4F, o-F);
UV–vis (toluene) lmax/nm (3/M
1 cm1) 418 (4.6105), 511
(3.6104), 544 (7.2103), 587 (1.1104), 643 (1.8103). Anal. Calcd
for C64H62F4N8O8S4: C, 60.27; H, 4.90; N, 8.79; S, 10.06. Found: C,
60.08; H, 4.67; N, 8.54; S, 10.75.4.6. 1-Octanol/water partition coefficients
The 1-octanol/water partition coefficients were measured fol-
lowing shake-flask method with minor modifications.38–40 The
sulfonamide halogenated porphyrin (8102 mmol) is dissolved in
5 mL of 1-octanol previously saturated with a solution of PBS
pH¼7.4. The same volume (5 mL) of a PBS solution, saturated with
1-octanol, was added to the 1-octanol phase, mixed vigorously for
3 min and then the phases were separated by centrifugation
(4000 rpm, 2 min). Longer contact times between the phases
were tested and shown not to influence the final results. One
aliquot of 3 mL was taken from each phase and diluted with
ethanol in order to attain the ratio ethanol/1-octanol (70:30) or
ethanol/PBS (70:30). The fluorescence of each ethanol/1-octanol
and ethanol/PBS solution was measured, and compared with
a calibration curve to obtain the concentration of the photo-
sensitizer. The solutions for the calibration curves were either
ethanol/1-octanol (70:30) or ethanol/PBS (70:30), and were both
prepared in a range of concentrations between 0.1 mM and 1 mM.
The Soret absorption band ca. 420 nm was excited, and the
fluorescence was collected in the red region, under the same in-
strumental conditions for both the solutions of the calibration
curve and the samples. The determination of log KOW for the
sulfonic acid porphyrin derivatives, 4f, 5f and 6f, was carried out
like the procedure described above, but initially the sensitizers
have been dissolved in PBS solution previously saturated with
1-octanol.
The partition coefficients were calculated from the ratio Coct/
CPBS, where Coct and CPBS are the concentrations of the porphyrin in
the 1-octanol and in the PBS, respectively. All the measurements
were carried out at room temperature.4.7. MALDI-TOFMS
DCTB matrix solution was made to a concentration of
20 mgmL1 in dichloromethane. DHB matrix solution was made to
a concentration of 10 mgmL1 in 1:1 (v/v) EtOH/MeCN. All com-
pounds were dissolved in dicloromethane, with the exception of 6f,
which was dissolved in EtOH, at an approximate concentration of
10 mgmL1. One microlitre of sample solution was vortex-mixed
with 49 mL of DCTB solution; 0.5 mL of the final mixture was spotted
onto the gold-plated, deep-welled, target plate and allowed to dry.
Compound 6f was analyzed using a similar procedure, but with
DHB matrix and a stainless steel target plate. The MALDI-TOFMS
spectrometer was operated in positive ion, reflectron mode, and
spectra were accumulated in multiples of 25 laser shots, with 100
shots in total. Postacquisition processing of data was performed
utilizing Data Explorer V4.0 software supplied by Applied
Biosystems. Theoretical isotope distributions were generated at
a resolution of 15,000 fwhm.Acknowledgements
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